Gardner, MA — Vn96 is a synthetic peptide that was designed to specifically stick to surface molecules on microvesicles (MVs) and exosomes. Microvesicles are a facsimile of a diseased cell that contain the same altered genes and proteins that you would find in a sample obtained from a more invasive surgical biopsy. Microvesicles circulate in […]
SANTA CLARA, Calif.- Agilent Technologies Inc. (NYSE: A) today announced that Fred Strohmeier, vice president and general manager of Agilent’s Life Science Products and Solutions, has been named senior vice president, Agilent, and president of Agilent’s Life Sciences and Diagnostics Group (LDG), effective immediately. Strohmeier has been in charge of Agilent’s life sciences business, the […]
GLOSTRUP, Denmark — Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, today introduced the latest version of “The Educational Guidebook: IHC Staining Methods.” Since Dako released the guidebook’s fifth edition in 2009, more than 20,000 copies have been published, plus an additional 3,000 online copies downloaded each year. This globally recognized book […]
Stony Brook, NY — CytoGenX Corp, a leading provider of medical genetic testing services, announced today it will be offering Assure™, its new comprehensive whole-genome microarray designed to aid in the detection and identification of disease-causing genetic alterations involved in prenatal and pediatric genetic diseases as well as cancer and infertility. “Assure™, is an unprecedented […]
New York, NY-– Enzo Biochem Inc. (NYSE:ENZ) and Flagship Biosciences LLC, of Boulder, CO, today announced a partnership in tissue-based companion diagnostics that will enable personalized diagnosis and treatment of disease. The firms are working jointly with pharmaceutical clients that require an independent complete solution to the delivery of an in situ hybridization (ISH) companion […]
SAN DIEGO and SAINT-OUEN-L’AUMONE, France– Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced that Laboratoire Cerba has launched its validated noninvasive prenatal test (NIPT) to health care providers and their patients in France, Belgium, Luxembourg and portions of the Middle East and Africa. Laboratoire Cerba’s test utilizes […]
SEATTLE and SAN ANTONIO, TX |NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced nationwide availability of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay beginning in the first quarter of 2014. Premier national diagnostic laboratories ARUP Laboratories, Laboratory Corporation of America® Holdings (LabCorp®) […]
Jena, Germany — Analytik Jena AG has appointed Dr. Marco Tilgner as the new managing director of the Japanese subsidiary AJ Japan as of January 1, 2014. Mr. Tilgner, who will report in his future role to Analytik Jena Chief Executive Officer Klaus Berka, already took over responsibility for finance and administration at the subsidiary […]
Cambridge, UK — Population Genetics Technologies Ltd (PGT) has exclusively licensed patent rights including US 8,481,292 covering its VeriTag™ technology to Agilent Technologies. PGT retains exclusive rights to develop and commercialize VeriTag™ for applications in human infectious disease diagnostics, and non-exclusive rights for veterinary diagnostics and plant genomic uses. VeriTag™ is a PGT proprietary technology […]
GLASGOW, Scotland — The King Abdulaziz City for Science and Technology (KACST), Saudi Arabia’s national funding agency, and Life Technologies Corporation (NASDAQ:LIFE) today announce The Saudi Human Genome Program — a national research project to study the genetic basis of all disease in the Kingdom and throughout the Middle East and use the findings to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
